Comparison of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in patients with thyroiditis and papillary tumors
Authors:
Open Access
- 26 March 2019
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 47 (5) , 2077-2083
Abstract
Objective: The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) have recently been introduced as prognostic markers of thyroid cancer and strong inflammatory markers. The study was performed to investigate the association of the PLR and NLR with thyroid inflammation and papillary cancer. Methods: Patients with thyroiditis and patients with papillary carcinomas were compared with sex-, age-, and body mass index-matched healthy controls. The NLR and PLR were calculated and compared among the three groups. Results: The NLR was significantly higher in patients with thyroiditis and non-significantly higher in patients with papillary cancer than in healthy controls. The PLR was significantly higher in both patients with thyroiditis and papillary cancer than in healthy controls. Like the NLR, the PLR was not different between patients with thyroiditis and papillary cancer. The NLR was significantly and positively associated with the PLR and white blood cell count. Conclusion: The PLR and NLR showed similar results in both thyroid inflammation and cancer. It seems difficult to obtain clear results in separating cancer from inflammatory events using these parameters. We suggest using them as supportive parameters of thyroid papillary cancer or inflammation.Keywords
Funding Information
- Istanbul Training and research hospital, Istanbul, Turkey (ITRH-2017-009-211)
This publication has 26 references indexed in Scilit:
- The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic ReviewClinical Genitourinary Cancer, 2016
- Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancerOncology Letters, 2016
- Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?Trends in Endocrinology & Metabolism, 2014
- Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patientsMedical Oncology, 2014
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisJNCI: Journal of the National Cancer Institute, 2014
- Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progressionBiomedicine & Pharmacotherapy, 2014
- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancerCritical Reviews in Oncology/Hematology, 2013
- The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot studyThe American Journal of Surgery, 2013
- Pretreatment Parameters Obtained from Peripheral Blood Sample Predicts Invasiveness of Bladder CarcinomaUrologia Internationalis, 2012
- Cancer-related inflammationNature, 2008